Evidence map›Paper›PMID 34927072›Full record

ArticleClinical pathology (Thousand Oaks, Ventura County, Calif.)

An Unusual Case of EBV-Negative Primary CNS Lymphoma of Natural Killer/T-Cell Lineage.

Naim I Kajtazi, Mohammed Bafaquh, Juman Al Ghamdi, Zahra AlEissa, Arwa Al Shmeikh, Ali Alsaeed, Tarek Sulaiman, M Adelita Vizcaino, Majed Al Hameed, Aditya Raghunathan

Open access · goldAbstract read
In one paragraph

Article in Clinical pathology (Thousand Oaks, Ventura County, Calif.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Naim I KajtaziDepartment of Neurology, National Neurosciences Institute, King Fahad Medical City, Riyadh, KSA.ORCID https://orcid.org/0000-0002-9983-3584
Mohammed BafaquhDepartment of Neurosurgery, National Neurosciences Institute, King Fahad Medical City, Riyadh, KSA.
Juman Al GhamdiMedical Imaging Administration, Neurointervention Radiology, King Fahad Medical City, Riyadh, KSA.
Zahra AlEissaDepartment of Neurology, National Neurosciences Institute, King Fahad Medical City, Riyadh, KSA.
Arwa Al ShmeikhDepartment of Neurosurgery, National Neurosciences Institute, King Fahad Medical City, Riyadh, KSA.
Ali AlsaeedInternal Medicine Department, Infectious Diseases, King Fahad Medical City, Riyadh, KSA.
Tarek SulaimanInternal Medicine Department, Infectious Diseases, King Fahad Medical City, Riyadh, KSA.
M Adelita VizcainoDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Majed Al HameedDepartment of Neurology, National Neurosciences Institute, King Fahad Medical City, Riyadh, KSA.
Aditya RaghunathanDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Neurosciences Institute · USKing Fahd Medical City · SAMayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extranodal NK/T-cell lymphoma (ENKTL) is a well-defined cytotoxic lymphoma strongly associated with Epstein-Barr virus (EBV) infection, commonly affecting the nasopharynx and upper aerodigestive tract. Primary central nervous system (CNS) involvement is rare, and only 17 cases were previously reported in the literature. Here, we report the case of a 44-year-old male admitted with a 3-month history of personality changes and progressive right leg weakness. Brain magnetic resonance imaging studies (MRIs) revealed multiple rim-enhancing brain lesions bilaterally. An extensive clinical and laboratory workup was unrevealing, and 2 brain biopsies were initially considered inconclusive. Pertinently, no systemic lymphoproliferative disorder was identified. The patient initially experienced remarkable clinical improvement with dexamethasone, pulse methylprednisolone, and rituximab therapy. However, he eventually had rapid clinical deterioration, was found to have increased brain lesions, and died nearly 6 months after the initial presentation. During this time, the second brain biopsy was found to show involvement by T-cell lymphoma of NK-cell lineage, which was EBV negative. No post-mortem examination was done to identify any systemic lymphoma. This case serves to expand the spectrum of lymphomas involving the CNS.

Indexed as

Epstein–Barr virus (EBV) infectionextranodal NK/T-cell lymphoma (ENKTL)NK (natural killer) cellsPrimary CNS lymphoma

Identifiers

PMID34927072
PMCPMC8671822
OpenAlexW4200244255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.